Efficacy News and Research

RSS
Positive results from Harbor BioSciences' Triolex initial preclinical study for treatment of PD

Positive results from Harbor BioSciences' Triolex initial preclinical study for treatment of PD

USPTO issues Notice of Allowance to Somaxon's Silenor patent application

USPTO issues Notice of Allowance to Somaxon's Silenor patent application

Regeneron submits VEGF Trap-Eye BLA to FDA for treatment of wet AMD

Regeneron submits VEGF Trap-Eye BLA to FDA for treatment of wet AMD

Infinity commences IPI-926 Phase 2 trial in patients with pancreatic cancer

Infinity commences IPI-926 Phase 2 trial in patients with pancreatic cancer

Nitroglycerin ointment may help in improving older women’s bone health: Study

Nitroglycerin ointment may help in improving older women’s bone health: Study

Pieris: New interim PRS-050 Phase I data against cancer to be presented at Tri-Conference in California

Pieris: New interim PRS-050 Phase I data against cancer to be presented at Tri-Conference in California

MedTrust, Avantra collaborate to develop molecular diagnostic assay for cancer care

MedTrust, Avantra collaborate to develop molecular diagnostic assay for cancer care

Educational intervention may increase awareness about kidney transplant recipients' risk of developing skin cancer

Educational intervention may increase awareness about kidney transplant recipients' risk of developing skin cancer

Pharming, Santarus begin RHUCIN Phase IIIb study in patients with Hereditary Angioedema

Pharming, Santarus begin RHUCIN Phase IIIb study in patients with Hereditary Angioedema

Positive results from TMC435 phase 2b PILLAR study in treatment-naive patients with HCV

Positive results from TMC435 phase 2b PILLAR study in treatment-naive patients with HCV

GE Healthcare, CDC collaborate to explore efficacy of actionable health alerts

GE Healthcare, CDC collaborate to explore efficacy of actionable health alerts

Investigational heart valve implanted in patient through small puncture hole in leg

Investigational heart valve implanted in patient through small puncture hole in leg

Advancell announces positive results from Acadra clinical study in Chronic Lymphocytic Leukemia

Advancell announces positive results from Acadra clinical study in Chronic Lymphocytic Leukemia

Mouse model could help develop new classes of antidepressant drugs

Mouse model could help develop new classes of antidepressant drugs

Proper wound care may treat skin infections effectively than antibiotics in children with MRSA

Proper wound care may treat skin infections effectively than antibiotics in children with MRSA

New study: Venus White Pro whitens teeth up to 8.4 shades with virtually no sensitivity

New study: Venus White Pro whitens teeth up to 8.4 shades with virtually no sensitivity

QRxPharma granted FDA pre-NDA meeting, further phase II data released

QRxPharma granted FDA pre-NDA meeting, further phase II data released

Experts caution against dangers of inflated expectations of genomic medicine

Experts caution against dangers of inflated expectations of genomic medicine

Protalix: New data from taliglucerase alfa, oral GCD trials to be presented at Lysosomal Disease Network Symposium

Protalix: New data from taliglucerase alfa, oral GCD trials to be presented at Lysosomal Disease Network Symposium

Phase I/II safety, efficacy data for Bellicum's BPX-101 presented at 2011 Genitourinary Cancers Symposium

Phase I/II safety, efficacy data for Bellicum's BPX-101 presented at 2011 Genitourinary Cancers Symposium

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.